Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Milestone Pharmaceuticals

Milestone Pharmaceuticals
2005 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
MIST STOCK SYMBOL
$20.99 SHARE PRICE (As of Friday Closing)
Description

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 1111 Dr.-Frederik-Philips Boulevard
  • Suite 420
  • Saint-Laurent, Quebec H4M 2X6
  • Canada

+1 (514) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Milestone Pharmaceuticals’s full profile, request a free trial.

Milestone Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$15.09 - $27.95 $514M $18.95 -$4.13 10.2K 24.5M

Milestone Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Enterprise Value 732,686
Revenue 0 0 0
EBITDA (41,145) (23,812) (8,260)
Net Income (39,526) (23,185) (8,086)
Total Assets 151,837 88,081 27,590
Total Debt 236
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Milestone Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Milestone Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Milestone Pharmaceuticals Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sova Pharmaceuticals Venture Capital-Backed San Diego, CA 00 00.000 00000000000 00.000
000000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
0000 000000000000 Venture Capital-Backed Cambridge, MA 00 0000 000000000000 0000
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
00000000 Formerly VC-backed Rockville, MD 0 000.00 00000000 000.00
To view this company’s complete list of competitors, request access »

Milestone Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Milestone Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Milestone Pharmaceuticals Executive Team (11)

Name Title Board
Seat
Contact
Info
Joseph Oliveto Chief Executive Officer & Board Member
Amit Hasija Chief Financial Officer & Chief Accounting Officer
Philippe Douville Ph.D Chief Scientific Officer & Founder
Lorenz Muller Executive
Douglas Wight Vice President, Drug Development

3 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

Milestone Pharmaceuticals Board Members (17)

Name Representing Role Since Contact
Info
Brian Dovey Domain Associates Board Observer 000 0000
Daniel Omstead Ph.D Tekla Capital Management Board Observer 000 0000
Debra Liebert Domain Associates Board Member 000 0000
Dion Madsen BDC Healthcare Venture Fund Board Member 000 0000
Joseph Oliveto Milestone Pharmaceuticals Chief Executive Officer & Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 17 board members. Get the full list »